Seres TherapeuticsMCRB
那斯達克 · USD
5.18
+0.27
(+5.50%)
收盤 09/02 03:53 (UTC+8)
09/02 03:53 (UTC+8)
Seres TherapeuticsMCRB
5.18
+0.27
(+5.50%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- 0.00
- 0.00
- 0.00
- 0.01
- -
- -
- -
- -
- -
- -
- -
- 24.79
- -18.26
- 105.59
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 736 | 358 | 438 | 351 | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 736 | 358 | 438 | 351 | - | - | - | - | - | - |
營業費用 | 22,009 | 21,265 | 19,815 | 22,828 | 24,881 | 27,236 | 28,835 | 29,171 | - | 39,586 |
研發費用 | 9,141 | 13,195 | 11,684 | 12,616 | 12,939 | 11,821 | 12,841 | 16,459 | 20,083 | 21,702 |
推銷及管理費用 | 7,061 | 8,070 | 8,131 | 10,212 | 11,942 | 15,415 | 15,994 | 12,712 | 16,410 | 17,884 |
非經常性項目費用 | 5,807 | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -21,273 | -20,907 | -19,377 | -22,477 | -24,881 | -27,236 | -28,835 | -29,171 | -36,493 | -39,586 |
其他收入及費用 | 25,854 | 994 | 4,042 | 30,681 | 5,026 | 59,918 | 13,198 | -21,864 | 3,885 | 4,116 |
利息費用 | - | - | - | - | - | - | - | - | 7,492 | 4,663 |
稅前純益 | 4,581 | -19,913 | -15,335 | 8,204 | -19,855 | 32,682 | -15,637 | -51,035 | -40,100 | -40,133 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | 4,581 | -19,913 | -15,335 | 8,204 | -19,855 | 32,682 | -15,637 | 88,776 | -32,870 | -40,133 |
基本每股稅後盈餘(元) | 0.47 | -2.08 | 1.78 | 0.94 | -2.27 | 0.19 | -0.09 | 0.58 | -0.22 | -0.27 |
稀釋每股稅後盈餘(元) | 0.49 | -2.08 | -1.76 | 0.93 | -2.28 | 0.19 | -0.10 | 0.60 | -0.22 | -0.27 |
基本平均股數(千股) | 9706.00 | 9582.00 | - | 8758.00 | 8743.00 | 174064.00 | 171341.00 | 152644.00 | 151512.00 | 146100.00 |
稀釋平均股數(千股) | 9747.00 | 9582.00 | - | 8771.00 | 8743.00 | 174294.00 | 171341.00 | 152644.00 | 151512.00 | 146100.00 |
還原基本每股稅後盈餘(元) | 0.47 | -2.08 | 1.78 | 0.94 | -2.27 | 3.76 | -0.09 | 11.63 | -4.34 | -5.49 |
還原稀釋每股稅後盈餘(元) | 0.49 | -2.08 | -1.76 | 0.93 | -2.28 | 3.75 | -2.10 | 11.91 | -4.32 | -5.49 |
還原基本平均股數(千股) | 9,706 | 9,582 | - | 8,758 | 8,743 | 8,703 | 171,341 | 7,632 | 7,575 | 7,305 |
還原稀釋平均股數(千股) | 9,747 | 9,582 | - | 8,771 | 8,743 | 8,714 | 171,341 | 7,632 | 7,575 | 7,305 |
EBITDA(千元) | 5,251 | -19,132 | -14,381 | 9,248 | -18,796 | 33,758 | -14,552 | 90,643 | -23,473 | -33,446 |